BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Kos Pharmaceutical Inc. 

1001 Brickell Bay Drive
25th Floor
Miami  Florida  33131  U.S.A.
Phone: 305-577-3464 Fax: 305-577-4596


SEARCH JOBS








 Company News
Abbott Laboratories (ABT) Subsidiary Kos Pharmaceuticals (KOSP) Reaches $41M Settlement 12/8/2010 7:55:20 AM    More...
Abbott Laboratories (ABT) Completes Acquisition Of Kos Pharmaceuticals (KOSP) 12/15/2006 10:38:30 AM    More...
Abbott Laboratories (ABT)' Acquisition Of Kos Pharmaceuticals (KOSP)' Clears Antitrust Review 12/5/2006 10:41:40 AM    More...
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Shares Of Kos Pharmaceuticals (KOSP) 11/14/2006 2:38:36 PM    More...
Kos Pharmaceuticals (KOSP) Reports A 17% Increase In Revenue, Earnings Per Share Of $0.71, And Solid Cash Flow From Operations 11/9/2006 11:46:11 AM    More...
Kos Pharmaceuticals (KOSP) To Report Third Quarter Results On November 9, 2006 Conference Call At 8:30 A.M. ET 11/3/2006 11:06:04 AM    More...
Merck & Co., Inc. (MRK) Revises Regulatory Filing Timeline For MK-0524B, An Investigational Fixed-Dose Combination Of MK-0524A And Simvastatin; Kos Pharmaceuticals (KOSP) Shares Rise On Merck Delay 9/29/2006 8:53:47 AM    More...
The Day In Review: Merck & Co., Inc. (MRK) Gets European Approval Of Gardasil 9/22/2006 7:09:31 PM    More...
Kos Pharmaceuticals (KOSP) Announces Overall Results For Two Phase III Trials Of Icatibant For The Treatment Of Hereditary Angioedema; Primary Endpoint Met In FAST-2 But Not Met In FAST-1 9/22/2006 9:14:27 AM    More...
Kos Pharmaceuticals (KOSP) To Present At The UBS Warburg Global Life Sciences Conference 9/19/2006 12:23:53 PM    More...
12345678910...

//-->